BriaCell Therapeutics Corp. (BCTX)
$3.69-0.54%Close
SELLRECOVERY · day 50
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $7M
- Beta
- 1.52
- P/E (TTM)
- -0.30
- Short % float
- 46.78%
- Days to cover
- 3.9
- SI change
- -1.7%
- 1W
- -7.75%
- 1M
- +3.07%
- vs SPY 1W
- -7.61%
- vs SPY 1M
- +0.57%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BCTX?
- LOPJLB’s latest quantitative signal on BriaCell Therapeutics Corp. (BCTX) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is BCTX in?
- BriaCell Therapeutics Corp. (BCTX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does BriaCell Therapeutics Corp. (BCTX) do?
- BriaCell Therapeutics Corp. is an immuno-oncology biotechnology company primarily focused on developing innovative immunotherapies to combat cancer. The firm's leading experimental drug, Bria-IMT, is currently undergoing Phase I/IIa clinical investigation. This crucial study evaluates its effectiveness when utilized in conjunction with immune checkpoint inhibitors for treating breast cancer. Be…